Zobrazeno 1 - 10
of 30
pro vyhledávání: '"J. Aquiles Sanchez"'
Publikováno v:
BioTechniques, Vol 32, Iss 5, Pp 1106-1111 (2002)
Amplification of DNA sequences from single cells via PCR is increasingly used in basic research and clinical diagnostics but remains technically difficult. We have developed a cell lysis protocol that uses an optimized proteinase K solution, named Qu
Externí odkaz:
https://doaj.org/article/c9b59e34fb834c18b72673829c8b4ecd
Autor:
Susana García-Silva, Cristina Vico-Alonso, Lisa Meyer, Daniel Enderle, J. Aquiles Sanchez, María del Mar Onteniente, Mikkel Noerholm, Johan Skog, José-Luis Rodríguez-Peralto, Pablo-Luis Ortiz-Romero, Héctor Peinado
Publikováno v:
Journal of Investigative Dermatology.
This study was approved by the institutional ethical review board (CEIC) of Hospital 12 de Octubre (Madrid, Spain) and institutional review board information is04.625 version September 26th2018 on Act 20/18 dated by November 13th2018. Written informe
Autor:
John Rice, Stefano Mariani, Maleeka Singh, Christopher T. Elliott, Amanda M. Naaum, J. Aquiles Sanchez, Zoe Bleicher, Marine Cusa, Robert Hanner, Lawrence J. Wangh, Ian Goodhead, Sarah J. Helyar
Publikováno v:
Naaum, A M, Cusa, M, Singh, M, Bleicher, Z, Elliott, C, Goodhead, I B, Hanner, R H, Helyar, S J, Mariani, S, Rice, J E, Wangh, L J & Sanchez, J A 2021, ' Validation of FASTFISH-ID: A new commercial platform for rapid fish species authentication via universal closed-tube barcoding ', Food Research International, vol. 141, 110035 . https://doi.org/10.1016/j.foodres.2020.110035
Seafood represents up to 20% of animal protein consumption in global food consumption and is a critical dietary and income resource for the world's population. Currently, over 30% of marine fish stocks are harvested at unsustainable levels, and the i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72248fa809890a705091641cd77d14c5
Autor:
John Rice, Arthur Reis, Kenneth Pierce, J. Aquiles Sanchez, Adam E. Osborne, Lawrence J. Wangh
Publikováno v:
Nature Protocols. 2:2429-2438
This protocol describes the design and execution of monoplex and multiplex linear-after-the-exponential (LATE)-PCR assays using a novel reagent, PrimeSafe, that suppresses all forms of mispriming. LATE-PCR is an advanced form of asymmetric amplificat
Publikováno v:
Proceedings of the National Academy of Sciences. 101:1933-1938
Conventional asymmetric PCR is inefficient and difficult to optimize because limiting the concentration of one primer lowers its melting temperature below the reaction annealing temperature. Linear-After-The-Exponential (LATE)–PCR describes a new p
Publikováno v:
Molecular Human Reproduction. 9:815-820
We present a method for rapid and accurate identification of the normal and DeltaF508 alleles of the cystic fibrosis (CF) gene in single human cells that utilizes LATE (linear after the exponential)-PCR, a newly invented form of asymmetric PCR. Detec
Autor:
Ravigadevi Sambanthamurthi, Lawrence J. Wangh, Adam E. Osborne, J. Aquiles Sanchez, Kenneth C. Hayes
Publikováno v:
Journal of AIDS & Clinical Research.
Addition of clinically-relevant levels of 3′-Azido-3′-deoxythymidine (AZT) to cultured HepG2 cells increases the number of reactive radical species (reactive oxygen and nitrogen species [ROS and RNS]) as well as random mutations in mitochondrial
Publikováno v:
BioTechniques. 32:1106-1111
Amplification of DNA sequences from single cells via PCR is increasingly used in basic research and clinical diagnostics but remains technically difficult. We have developed a cell lysis protocol that uses an optimized proteinase K solution, named Qu
Publikováno v:
Scientific Reports
Detection of rare mutant alleles in an excess of wild type alleles is increasingly important in cancer diagnosis. Several methods for selective amplification of a mutant allele via the polymerase chain reaction (PCR) have been reported, but each of t
Background: Numerous mutations in exons 18-21 of the epidermal growth factor receptor (EGFR) gene determine the response of many patients with Non-Small Cell Lung Carcinoma (NSCLC) to anti-EGFR Tyrosine Kinase Inhibitors (TKIs). This paper describes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e0ada4e3c8708e6ed4ecbf089afc41c
https://europepmc.org/articles/PMC4234171/
https://europepmc.org/articles/PMC4234171/